Dr. Rajeev Saggar - 05 Nov 2025 Form 4 Insider Report for Liquidia Corp (LQDA)

Role: Chief Medical Officer
Signature: /s/ Dr. Rajeev Saggar
Issuer symbol: LQDA
Transactions as of: 05 Nov 2025
Net transactions value: -$1,927,287
Form type: 4
Filing time: 07 Nov 2025, 16:30:44 UTC
Previous filing: 15 Oct 2025
Next filing: 13 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Saggar Rajeev	Chief Medical Officer	419 DAVIS DRIVE, SUITE 100, MORRISVILLE	/s/ Dr. Rajeev Saggar	07 Nov 2025	0001935638

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LQDA	Common Stock	Sale	$132,786	-4,918	-2%	$27.00	243,012	05 Nov 2025	Direct	F1
transaction	LQDA	Common Stock	Sale	$1,794,501	-66,463	-27%	$27.00	176,549	05 Nov 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes (i) 26,041 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 31,777 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 71,780 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4, and (iv) 2,221 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.

Content

Includes (i) 26,041 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 31,777 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 71,780 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4, and (iv) 2,221 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.